American Society of Hematology

SHERPA: Blue

People

  1. Hamlin
    Hamlin
  2. Kumar
    Kumar
  3. Moskowitz
    Moskowitz
  4. Zelenetz
    Zelenetz
  5. Caron
    Caron
  6. Drullinsky
    Drullinsky
  7. Horwitz
    Horwitz
  8. Noy
    Noy
  9. Palomba
    Palomba
  10. Intlekofer
    Intlekofer

Groups

  1. Department of Medicine (9)
  2. Hematologic Malignancies, Division of (9)
  3. Center for Hematologic Malignancies (5)
  4. Lymphoma (5)
  5. Biostatistics Service (4)
  6. Epidemiology and Biostatistics (4)
  7. Executive Committee, Center for Hematologic Malignancies (4)
  8. Breast Medicine Service (3)
  9. Nursing (3)
  10. Population Sciences Research Program (3)
Search Within
  1. "2016"
  2. "Craig Moskowitz"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Department of Medicine (9)
  2. Hematologic Malignancies, Division of (9)
  3. Center for Hematologic Malignancies (5)
  4. Lymphoma (5)
  5. Biostatistics Service (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Craig Moskowitz (9)
  2. Alison Moskowitz (4)
  3. Anas Younes (4)
  4. Andrew Zelenetz (4)
  5. Anita Kumar (4)
  6. Carol Portlock (4)

More People

Years
  1. 2016 (9)
Publications
  1. Blood (8)
  2. Hematology-American Society of Hematology Education Program (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab in relapsed/refractory classical Hodgkin lymphoma: Primary end point analysis of the phase 2 keynote-087 study
    Meeting Abstract

    Moskowitz, C. H.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N. A.; Radford, J. A.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; Tomita, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Preliminary results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
    Meeting Abstract

    Herrera, A. F.; Bartlett, N. L.; Ramchandren, R.; Vose, J. M.; Moskowitz, A. J.; Feldman, T. A.; LaCasce, A. S.; Ansell, S. M.; Moskowitz, C. H.; Fenton, K.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase 1b study of embrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma: Results from the ongoing KEYNOTE-013 trial
    Meeting Abstract

    Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Zhang, Y.; Marinello, P.; Chlosta, S.; Gustafson, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The use of a novel CME format to ellicit and develop true competence in hematologist ability to risk stratify patients with Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, C. H.; Repetto, P.
    Blood (2016)

    Fulltext@MSK | Save
  • Outcome of initial observation in mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Ying, Z.; Alperovich, A.; Dogan, A.; Hamlin, P. A. Jr; Moskowitz, C. H.; Portlock, C. S.; Zelenetz, A. D.; Zhang, Z.; Woo, K. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, C.
    Hematology-American Society of Hematology Education Program (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schòˆder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save